Delivery Order SPE2DB25D7056-SPE2DB25FTMTJ
- Not listed
- The Defense Logistics Agency awarded a $1,295.97 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials under a firm fixed-price contract structure. The award was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation. This award represents a child contract executed under...
- The Defense Logistics Agency awarded a delivery order valued at $1,427.96 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. This contract, awarded on August 28, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively procured through open...
- The Defense Logistics Agency awarded a $1,454.70 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ketorolac 30 mg/mL vials. This is a firm fixed-price contract with no set-aside designation, reflecting competitive procurement on open terms. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order represents a single transaction under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,058.40 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials on August 6, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 7, 2025, represents a competitive award with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under...
- The Defense Logistics Agency awarded a $2,424.50 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ketorolac 30 mg/mL vials. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The contract was competitively awarded with no set-aside designation, and performance will be fulfilled from...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,194.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ketorolac 30 mg/ml vials. The contract is a non-set-aside competitive award with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Ketorolac 30 mg/mL vials valued at $1,298.52. This award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive selection among qualified vendors. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. As a child...
- The Defense Logistics Agency has awarded a delivery order valued at $2,909.40 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. This competitive award, issued on August 19, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025. The pharmaceutical distributor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $7,130.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Ketorolac 30 mg/ml vials. This non-set-aside contract is scheduled for completion by June 2, 2025, and represents a routine pharmaceutical procurement supporting federal medical supply needs. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for Ketorolac 30 mg/mL vials with a ceiling value of $2,472.26. This firm fixed-price delivery order represents a non-competitive set-aside contract and carries an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTMTJDelivery Order
The Defense Logistics Agency awarded a $1,086.88 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials under a firm fixed price contract type. The award was issued on July 11, 2025, with an ultimate completion date of July 14, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Ketorolac delivery order exemplifies the routine pharmaceutical procurement executed through this IDC framework, providing critical pain management medication for federal military and healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/11/25 |